CPT code 55711: Prostate biopsy, transrectal fusion, first lesion2026 Medicare rate & RVUs in Louisiana
Reports transrectal prostate biopsy using MRI-ultrasound fusion to target and sample the first suspicious lesion identified on prostate imaging.
Medicare pays $336.04–$353.16 for 55711 in the office in Louisiana, from Rest of Louisiana to New Orleans, LA. Which amount applies depends on the service address.
Medicare allowed amount for participating (non-QP) physicians, before deductible, coinsurance and claim adjustments. Not a patient’s bill or a hospital charge.
Your location
On this page 9 sections
What 55711 covers
A urologist uses transrectal ultrasound fused with previously obtained prostate MRI images to guide a needle to the first suspicious lesion and collect tissue samples. This approach is commonly used when prostate MRI identifies a target, such as during evaluation of an elevated PSA or after a prior biopsy. The code represents the first lesion sampled through this transrectal fusion technique, not each needle core.
Report the code when the documented biopsy uses MRI-ultrasound image fusion and samples a target through the rectum. Record the approach, fusion guidance, target lesion, and sampling performed; use 55715 for each additional lesion when applicable. CMS assigns a 0-day global period, so same-day preoperative and postoperative care is included. When multiple procedures occur in the same session, the highest-valued procedure is paid in full and other procedures are subject to the standard 50% reduction. Assistant-at-surgery payment requires documentation of medical necessity; co-surgeons and team surgery are not permitted. Bilateral adjustment does not apply.
This summary was written with AI assistance from CMS physician fee schedule data and checked against the CMS billing rules shown here. Rates on this page come directly from CMS files.
Where 55711 pays more and less in Louisiana
| Payment locality | Office | Facility |
|---|---|---|
| New Orleans, LA | $353.16 | $135.03 |
| Rest of Louisiana | $336.04 | $130.89 |
How the 55711 rate is calculated
Each of 55711’s three RVUs is multiplied by a geographic index (GPCI) for the payment locality, added up, and multiplied by the conversion factor. Drag the indexes or enter a ZIP to see what moves the rate.
How the rate is built · 55711
RVUs × geographic indexes × conversion factor
Work2.61
2.61 RVUs× 1.000 GPCI
Practice expense8.04
8.04 RVUs× 1.000 GPCI
Malpractice0.35
0.35 RVUs× 1.000 GPCI
Adjusted RVUs
11.0000
Conversion factor
$33.4009
Medicare rate
$367.41
Every GPCI starts at 1.000, the national rate. Enter a ZIP or drag a slider.
Payment rules and modifiers for 55711
The CMS indicators that decide how 55711 is paid alongside other services.
CMS payment indicators · 55711
Prostate biopsy, transrectal fusion, first lesion
| Rule | CMS value | What it means |
|---|---|---|
| Global period | 000 | Same-day global: pre- and post-op care on the day of the procedure is included. |
| Multiple procedures | 2 | Standard reduction: highest-valued procedure at 100%, others at 50%. |
| Bilateral (modifier 50) | 0 | The 150% bilateral adjustment doesn’t apply. |
| Assistant at surgery (80/81/82/AS) | 0 | Not paid without supporting documentation. |
| Co-surgeons (62) | 0 | Not permitted. |
| Team surgery (66) | 0 | Not permitted. |
| Professional/technical | 0 | Physician service: no professional/technical split. |
What modifiers do to the payment
Modifier 51 · payment effect
With and without the modifier
55711 without 51 · national office
$367.41
Prostate biopsy, transrectal fusion, first lesion
55711-51 · Second procedure: 50%
$183.71
When this isn’t the highest-valued procedure in the session, Medicare pays 50% of its fee schedule amount (the highest is paid at 100%).
55711 compared with similar codes
Compare codes · National
4 codes, side by side
How to choose
- 55707Prostate biopsyTransrectal, ultrasound guided
- 55707 describes transrectal ultrasound-guided prostate biopsy. Choose 55711 when MRI-ultrasound fusion is used to target the lesion.
- 55712Prostate biopsyTransperineal fusion, first lesion
- Both involve MRI-ultrasound fusion and the first target lesion; 55711 is transrectal, while 55712 uses a transperineal approach.
- 55713Prostate biopsyIn-bore CT or MRI guidance
- 55713 is for in-bore CT or MRI-guided biopsy. 55711 uses fused MRI and real-time ultrasound guidance.
55711 billing questions
When should 55711 be chosen instead of 55707?
Use 55711 when the transrectal biopsy uses MRI-ultrasound fusion to target an MRI-identified lesion. Code 55707 describes transrectal biopsy with ultrasound guidance without the MRI-fusion distinction.
Does each core from the first target support another unit?
No. The code covers sampling the first lesion; multiple cores from that same target do not turn it into multiple lesions.
How is a second MRI target reported?
Use 55715 for each additional lesion sampled, when the service meets that add-on code’s requirements.
Can modifier 50 be reported?
No. CMS identifies bilateral adjustment as inapplicable for this code, and modifier 50 is inappropriate for the prostate biopsy.
What documentation supports 55711?
Document the transrectal route, MRI-ultrasound fusion guidance, the target lesion, and the biopsy sampling performed.
Where these rates come from
FeeBase calculates base physician payments from CMS work, practice-expense and malpractice RVUs, adjusted by each locality’s geographic indexes and the conversion factor. Services without a published rate are labeled, never given a made-up amount. Amounts are Medicare allowed amounts before claim adjustments: not a patient’s bill or a commercial rate.
CMS RVU26D · effective Oct 1, 2026 through the day before Jan 1, 2027
Show the CMS file lines behind this rate
Fee sheets · Coming soon
Put 55711 and the rest of your codes on one sheet
Your codes at your locality, with payer contracts beside Medicare.
Join the waitlist